RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Pancreatic Cancer Therapy Area Pipeline Report
Nov 2010 - 538 pages - $1,495
Pancreatic Cancer - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
Metastatic Pancreatic Cancer - Pipeline Review, Q3 2011
Jul 2011 - 321 pages - $500
Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market
May 2011 - 7 pages - $500
GV1001 (Pancreatic Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 25 pages - $2,000
AMG479 (Pancreatic Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 26 pages - $2,000
Masitinib (Pancreatic Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 34 pages - $2,000
Sutent (Pancreatic Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 32 pages - $2,000
Metastatic Pancreatic Cancer - Pipeline Review, Q1 2011
Jan 2011 - 96 pages - $500
Tarceva (Pancreatic cancer) – Analysis and Forecasts to 2020
Oct 2011 - 34 pages - $2,000
More Related Market Research Reports >>>

Your selection

Industry sector
Drug delivery del
Topical del
Dermatological del
Foam del
Therapeutic target
Oncology del
Pancreatic cancer del
Development phase
Early Stage del

Browse By

Therapeutic target
Adenocarcinoma
Pancreatic cancer exocrine

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us